{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:39:04Z","timestamp":1793248744911,"version":"4.5.0"},"reference-count":68,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T00:00:00Z","timestamp":1573171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100007890","name":"University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008615","name":"Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008615","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["PO1\\u2013CA019014-37"],"award-info":[{"award-number":["PO1\\u2013CA019014-37"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-CA096500"],"award-info":[{"award-number":["R01-CA096500"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.antiviral.2019.104649","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T12:35:58Z","timestamp":1573216558000},"page":"104649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"special_numbering":"C","title":["Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1"],"prefix":"10.1016","volume":"173","author":[{"given":"Sage L.","family":"Atkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Safiyyah","family":"Motaib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura C.","family":"Wiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon E.","family":"Hopcraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul B.","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Shackelford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Foote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley H.","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blossom","family":"Damania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth H.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Whitehurst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2019.104649_bib1","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1128\/JVI.01895-10","article-title":"A single mutation responsible for temperature-sensitive entry and assembly defects in the VP1-2 protein of herpes simplex virus","volume":"85","author":"Abaitua","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib2","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1002\/cncr.20655","article-title":"Quality of life impact of three different doses of suramin in patients with metastatic hormone-refractory prostate carcinoma: results of Intergroup O159\/Cancer and Leukemia Group B 9480","volume":"101","author":"Ahles","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.antiviral.2019.104649_bib3","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.antiviral.2015.06.013","article-title":"Suramin inhibits chikungunya virus replication through multiple mechanisms","volume":"121","author":"Albulescu","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104649_bib4","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.antiviral.2017.04.016","article-title":"Suramin inhibits Zika virus replication by interfering with virus attachment and release of infectious particles","volume":"143","author":"Albulescu","year":"2017","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2019.104649_bib5","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1128\/jvi.45.1.397-407.1983","article-title":"Molecular genetics of herpes simplex virus. VIII. further characterization of a temperature-sensitive mutant defective in release of viral DNA and in other stages of the viral reproductive cycle","volume":"45","author":"Batterson","year":"1983","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib6","doi-asserted-by":"crossref","first-page":"13403","DOI":"10.1128\/JVI.01643-07","article-title":"Identification of functional domains within the essential large tegument protein pUL36 of pseudorabies virus","volume":"81","author":"Bottcher","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib7","doi-asserted-by":"crossref","first-page":"6009","DOI":"10.1128\/JVI.00280-08","article-title":"Mutagenesis of the active-site cysteine in the ubiquitin-specific protease contained in large tegument protein pUL36 of pseudorabies virus impairs viral replication in vitro and neuroinvasion in vivo","volume":"82","author":"Bottcher","year":"2008","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib8","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1002\/art.38772","article-title":"Differential regulatory role of pituitary adenylate cyclase-activating polypeptide in the serum-transfer arthritis model","volume":"66","author":"Botz","year":"2014","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.antiviral.2019.104649_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/imm.12808","article-title":"Programmed death 1 is highly expressed on CD8+ CD57+ T cells in patients with stable multiple sclerosis and inhibits their cytotoxic response to Epstein-Barr virus","author":"Cencioni","year":"2017","journal-title":"Immunology"},{"key":"10.1016\/j.antiviral.2019.104649_bib10","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1111\/j.1476-5381.1996.tb15457.x","article-title":"PPADS and suramin as antagonists at cloned P2Y- and P2U-purinoceptors","volume":"118","author":"Charlton","year":"1996","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104649_bib11","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/nm0897-866","article-title":"Dengue virus infectivity depends on envelope protein binding to target cell heparan sulfate","volume":"3","author":"Chen","year":"1997","journal-title":"Nat. Med."},{"key":"10.1016\/j.antiviral.2019.104649_bib12","doi-asserted-by":"crossref","first-page":"107fs107","DOI":"10.1126\/scitranslmed.3002878","article-title":"Epstein-Barr virus: an important vaccine target for cancer prevention","volume":"3","author":"Cohen","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2019.104649_bib13","doi-asserted-by":"crossref","first-page":"8245","DOI":"10.1073\/pnas.95.14.8245","article-title":"Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells","volume":"95","author":"Delecluse","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.antiviral.2019.104649_bib14","doi-asserted-by":"crossref","first-page":"11608","DOI":"10.1128\/JVI.74.24.11608-11618.2000","article-title":"A null mutation in the UL36 gene of herpes simplex virus type 1 results in accumulation of unenveloped DNA-filled capsids in the cytoplasm of infected cells","volume":"74","author":"Desai","year":"2000","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1021\/ed038p620","article-title":"The discovery of germanin by oskar Dressel and richard Kothe","volume":"38","author":"Dressel","year":"1961","journal-title":"J. Chem. Educ."},{"key":"10.1016\/j.antiviral.2019.104649_bib16","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.autrev.2011.08.005","article-title":"Autoimmune disease: a role for new anti-viral therapies?","volume":"11","author":"Dreyfus","year":"2011","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.antiviral.2019.104649_bib17","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00600-17","article-title":"The translesion polymerase pol eta is required for efficient epstein-barr virus infectivity and is regulated by the viral deubiquitinating enzyme BPLF1","volume":"91","author":"Dyson","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1000605","article-title":"Enzymatic blockade of the ubiquitin-proteasome pathway","volume":"8","author":"Ernst","year":"2011","journal-title":"PLoS Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib19","first-page":"81","article-title":"Recherches de chimioth\u00e9rapie dans la s\u00e9rie du 205 Bayer. Ur\u00e9es des acides aminobenzoylaminonaphtal\u00e9niques","volume":"38","author":"Fourneau","year":"1924","journal-title":"Ann. Inst. Pasteur."},{"key":"10.1016\/j.antiviral.2019.104649_bib20","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/S0026-895X(25)08769-3","article-title":"Suramin analogues as subtype-selective G protein inhibitors","volume":"49","author":"Freissmuth","year":"1996","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104649_bib21","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb2035","article-title":"A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases","volume":"12","author":"Gastaldello","year":"2010","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1093\/jmcb\/mjs012","article-title":"Herpes virus deneddylases interrupt the cullin-RING ligase neddylation cycle by inhibiting the binding of CAND1","volume":"4","author":"Gastaldello","year":"2012","journal-title":"J. Mol. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003664","article-title":"Caspase-1 promotes epstein-barr virus replication by targeting the large tegument protein deneddylase to the nucleus of productively infected cells","volume":"9","author":"Gastaldello","year":"2013","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104649_bib24","doi-asserted-by":"crossref","unstructured":"Gastaldello S, Hildebrand S, Faridani O, Callegari S, Palmkvist M, Di Guglielmo C, Masucci MG. A deneddylase encoded by Epstein-Barr virus promotes viral DNA replication by regulating the activity of cullin-RING ligases. Nat. Cell Biol. 12:351-361.","DOI":"10.1038\/ncb2035"},{"key":"10.1016\/j.antiviral.2019.104649_bib25","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/jac\/dki240","article-title":"Epstein-Barr virus infections: prospects for treatment","volume":"56","author":"Gershburg","year":"2005","journal-title":"J. Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2019.104649_bib26","doi-asserted-by":"crossref","first-page":"10224","DOI":"10.1128\/JVI.00589-09","article-title":"Kaposi's sarcoma-associated herpesvirus encodes a viral deubiquitinase","volume":"83","author":"Gonzalez","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006852","article-title":"Herpesvirus deconjugases inhibit the IFN response by promoting TRIM25 autoubiquitination and functional inactivation of the RIG-I signalosome","volume":"14","author":"Gupta","year":"2018","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104649_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1186\/s12985-016-0607-2","article-title":"Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry","volume":"13","author":"Henss","year":"2016","journal-title":"Virol. J."},{"key":"10.1016\/j.antiviral.2019.104649_bib29","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/BF03402095","article-title":"beta-lapachone induces cell cycle arrest and apoptosis in human colon cancer cells","volume":"5","author":"Huang","year":"1999","journal-title":"Mol. Med."},{"key":"10.1016\/j.antiviral.2019.104649_bib30","doi-asserted-by":"crossref","first-page":"10899","DOI":"10.1128\/JVI.00690-11","article-title":"Inhibition of RIG-I-mediated signaling by Kaposi's sarcoma-associated herpesvirus-encoded deubiquitinase ORF64","volume":"85","author":"Inn","year":"2011","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib31","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/BOR.0b013e3283535801","article-title":"Lupus and epstein-barr","volume":"24","author":"James","year":"2012","journal-title":"Curr. Opin. Rheumatol."},{"key":"10.1016\/j.antiviral.2019.104649_bib32","series-title":"William Ellery Channing, Professor of Medicine, Professor of Microbiology, Department of Microbiology and Immunobiology, Harvard Medical School, Division of Infectious Diseases, Brigham and Women's Hospital, Boston, Massachusetts and Five Others","article-title":"Harrison's principles of internal medicine","author":"Kasper","year":"2015"},{"key":"10.1016\/j.antiviral.2019.104649_bib33","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S1474-4422(12)70296-X","article-title":"Clinical features, diagnosis, and treatment of human African trypanosomiasis (sleeping sickness)","volume":"12","author":"Kennedy","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.antiviral.2019.104649_bib34","doi-asserted-by":"crossref","first-page":"12046","DOI":"10.1128\/JVI.00411-09","article-title":"Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells","volume":"83","author":"Kim","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib35","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1146\/annurev-biochem-060310-170328","article-title":"The ubiquitin code","volume":"81","author":"Komander","year":"2012","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.antiviral.2019.104649_bib36","doi-asserted-by":"crossref","first-page":"6411","DOI":"10.1128\/JVI.00536-14","article-title":"The Rad6\/18 ubiquitin complex interacts with the Epstein-Barr virus deubiquitinating enzyme, BPLF1, and contributes to virus infectivity","volume":"88","author":"Kumar","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib37","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1212\/WNL.0000000000004412","article-title":"Epstein-Barr virus, cytomegalovirus, and multiple sclerosis susceptibility: a multiethnic study","volume":"89","author":"Langer-Gould","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.antiviral.2019.104649_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.msard.2017.05.009","article-title":"Epstein-Barr virus and multiple sclerosis: updating Pender's hypothesis","volume":"16","author":"Laurence","year":"2017","journal-title":"Mult Scler Relat Disord"},{"key":"10.1016\/j.antiviral.2019.104649_bib39","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/0140-6736(91)91837-K","article-title":"Epstein-Barr virus in AIDS-related primary central nervous system lymphoma","volume":"338","author":"MacMahon","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2019.104649_bib40","doi-asserted-by":"crossref","first-page":"14713","DOI":"10.1074\/jbc.M312488200","article-title":"Suramin derivatives as inhibitors and activators of protein-tyrosine phosphatases","volume":"279","author":"McCain","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.antiviral.2019.104649_bib41","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2174\/138955708786369573","article-title":"Suramin: clinical uses and structure-activity relationships","volume":"8","author":"McGeary","year":"2008","journal-title":"Mini Rev. Med. Chem."},{"key":"10.1016\/j.antiviral.2019.104649_bib42","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.biocel.2004.03.007","article-title":"Suramin interaction with human alpha-thrombin: inhibitory effects and binding studies","volume":"36","author":"Monteiro","year":"2004","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib43","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1016\/j.jmb.2005.04.072","article-title":"Inhibition of myotoxic activity of Bothrops asper myotoxin II by the anti-trypanosomal drug suramin","volume":"350","author":"Murakami","year":"2005","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib44","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/acn3.424","article-title":"Low-dose suramin in autism spectrum disorder: a small, phase I\/II, randomized clinical trial","volume":"4","author":"Naviaux","year":"2017","journal-title":"Ann Clin Transl Neurol"},{"key":"10.1016\/j.antiviral.2019.104649_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005184","article-title":"The suramin derivative NF449 interacts with the 5-fold vertex of the enterovirus A71 capsid to prevent virus attachment to PSGL-1 and heparan sulfate","volume":"11","author":"Nishimura","year":"2015","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104649_bib46","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1136\/bmj.1.3297.413","article-title":"Synthetic therapeutic agents","volume":"1","author":"Pope","year":"1924","journal-title":"Br. Med. J."},{"key":"10.1016\/j.antiviral.2019.104649_bib47","first-page":"297","article-title":"Epstein-Barr virus and nasopharyngeal carcinoma","volume":"3","author":"Raab-Traub","year":"1992","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.antiviral.2019.104649_bib48","doi-asserted-by":"crossref","first-page":"4060","DOI":"10.1128\/JVI.02020-12","article-title":"Epstein-Barr virus deubiquitinase downregulates TRAF6-mediated NF-kappaB signaling during productive replication","volume":"87","author":"Saito","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib49","doi-asserted-by":"crossref","first-page":"15582","DOI":"10.1128\/JVI.79.24.15582-15585.2005","article-title":"A deubiquitinating activity is conserved in the large tegument protein of the herpesviridae","volume":"79","author":"Schlieker","year":"2005","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib50","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.molcel.2007.01.033","article-title":"Structure of a herpesvirus-encoded cysteine protease reveals a unique class of deubiquitinating enzymes","volume":"25","author":"Schlieker","year":"2007","journal-title":"Mol. Cell"},{"key":"10.1016\/j.antiviral.2019.104649_bib51","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.str.2007.02.002","article-title":"Structural basis of inhibition of the human NAD+-dependent deacetylase SIRT5 by suramin","volume":"15","author":"Schuetz","year":"2007","journal-title":"Structure"},{"key":"10.1016\/j.antiviral.2019.104649_bib52","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1021\/cr980431o","article-title":"Gold-based therapeutic agents","volume":"99","author":"Shaw","year":"1999","journal-title":"Chem. Rev."},{"key":"10.1016\/j.antiviral.2019.104649_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1756-3305-3-15","article-title":"The development of drugs for treatment of sleeping sickness: a historical review","volume":"3","author":"Steverding","year":"2010","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.antiviral.2019.104649_bib54","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1002\/cmdc.200700003","article-title":"Structure-activity studies on suramin analogues as inhibitors of NAD+-dependent histone deacetylases (sirtuins)","volume":"2","author":"Trapp","year":"2007","journal-title":"ChemMedChem"},{"key":"10.1016\/j.antiviral.2019.104649_bib55","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1003960","article-title":"Epstein-Barr virus large tegument protein BPLF1 contributes to innate immune evasion through interference with toll-like receptor signaling","volume":"10","author":"van Gent","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.antiviral.2019.104649_bib56","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.virol.2004.03.049","article-title":"Use of the red fluorescent protein as a marker of Kaposi's sarcoma-associated herpesvirus lytic gene expression","volume":"325","author":"Vieira","year":"2004","journal-title":"Virology"},{"key":"10.1016\/j.antiviral.2019.104649_bib57","doi-asserted-by":"crossref","first-page":"6003","DOI":"10.1128\/JVI.00401-06","article-title":"High-molecular-weight protein (pUL48) of human cytomegalovirus is a competent deubiquitinating protease: mutant viruses altered in its active-site cysteine or histidine are viable","volume":"80","author":"Wang","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib58","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease","volume":"320","author":"Weiss","year":"1989","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.antiviral.2019.104649_bib59","doi-asserted-by":"crossref","first-page":"4345","DOI":"10.1128\/JVI.02195-08","article-title":"The Epstein-Barr virus (EBV) deubiquitinating enzyme BPLF1 reduces EBV ribonucleotide reductase activity","volume":"83","author":"Whitehurst","year":"2009","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib60","doi-asserted-by":"crossref","first-page":"8097","DOI":"10.1128\/JVI.00588-12","article-title":"Epstein-Barr virus BPLF1 deubiquitinates PCNA and attenuates polymerase eta recruitment to DNA damage sites","volume":"86","author":"Whitehurst","year":"2012","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib61","doi-asserted-by":"crossref","first-page":"5311","DOI":"10.1128\/JVI.03505-12","article-title":"Maribavir inhibits Epstein-Barr virus transcription through the EBV protein kinase","volume":"87","author":"Whitehurst","year":"2013","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib62","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01574-15","article-title":"Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice","volume":"6","author":"Whitehurst","year":"2015","journal-title":"mBio"},{"key":"10.1016\/j.antiviral.2019.104649_bib63","doi-asserted-by":"crossref","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","article-title":"DrugBank 5.0: a major update to the DrugBank database for 2018","volume":"46","author":"Wishart","year":"2018","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.antiviral.2019.104649_bib64","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/sj.bjp.0706359","article-title":"Use-dependent inhibition of the skeletal muscle ryanodine receptor by the suramin analogue NF676","volume":"146","author":"Wolner","year":"2005","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104649_bib65","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bcp.2014.01.022","article-title":"Novel anti-inflammatory function of NSC95397 by the suppression of multiple kinases","volume":"88","author":"Yang","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.antiviral.2019.104649_bib66","doi-asserted-by":"crossref","first-page":"2548","DOI":"10.1128\/JVI.80.5.2548-2565.2006","article-title":"Virus and cell RNAs expressed during Epstein-Barr virus replication","volume":"80","author":"Yuan","year":"2006","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib67","doi-asserted-by":"crossref","first-page":"12987","DOI":"10.1128\/JVI.78.23.12987-12995.2004","article-title":"Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties","volume":"78","author":"Zhang","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.antiviral.2019.104649_bib68","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1038\/2281056a0","article-title":"EBV DNA in biopsies of Burkitt tumours and anaplastic carcinomas of the nasopharynx","volume":"228","author":"zur Hausen","year":"1970","journal-title":"Nature"}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354219304061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T21:11:16Z","timestamp":1777497076000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354219304061"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":68,"alternative-id":["S0166354219304061"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104649","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Small molecule screening identifies inhibitors of the Epstein-Barr virus deubiquitinating enzyme, BPLF1","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2019.104649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104649"}}